- Home
- INDP vs IBG Comparison
INDP vs IBG Comparison
Compare INDP & IBG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INDP
- IBG
- Stock Information
- Founded
- INDP 2000
- IBG 2018
- Country
- INDP United States
- IBG Australia
- Employees
- INDP N/A
- IBG N/A
- Industry
- INDP Biotechnology: Pharmaceutical Preparations
- IBG Beverages (Production/Distribution)
- Sector
- INDP Health Care
- IBG Consumer Staples
- Exchange
- INDP Nasdaq
- IBG Nasdaq
- Market Cap
- INDP 6.0M
- IBG 5.4M
- IPO Year
- INDP N/A
- IBG 2024
- Fundamental
- Price
- INDP $2.41
- IBG $0.36
- Analyst Decision
- INDP Strong Buy
- IBG Strong Buy
- Analyst Count
- INDP 2
- IBG 1
- Target Price
- INDP $238.00
- IBG N/A
- AVG Volume (30 Days)
- INDP 199.1K
- IBG 603.6K
- Earning Date
- INDP 11-11-2025
- IBG 11-15-2025
- Dividend Yield
- INDP N/A
- IBG N/A
- EPS Growth
- INDP N/A
- IBG N/A
- EPS
- INDP N/A
- IBG N/A
- Revenue
- INDP N/A
- IBG $2,931,243.00
- Revenue This Year
- INDP N/A
- IBG N/A
- Revenue Next Year
- INDP N/A
- IBG N/A
- P/E Ratio
- INDP N/A
- IBG N/A
- Revenue Growth
- INDP N/A
- IBG N/A
- 52 Week Low
- INDP $2.22
- IBG $0.30
- 52 Week High
- INDP $58.24
- IBG $3.35
- Technical
- Relative Strength Index (RSI)
- INDP 22.05
- IBG 33.07
- Support Level
- INDP $2.22
- IBG $0.30
- Resistance Level
- INDP $2.86
- IBG $0.48
- Average True Range (ATR)
- INDP 0.67
- IBG 0.07
- MACD
- INDP -0.18
- IBG -0.01
- Stochastic Oscillator
- INDP 3.86
- IBG 18.05
About INDP Indaptus Therapeutics Inc.
Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.
About IBG Innovation Beverage Group Limited Ordinary Shares
Innovation Beverage Group Ltd is a developer, manufacturer, marketer, exporter, and retailer of a growing beverage portfolio of 70 formulations across 14 alcoholic and non-alcoholic brands. The company's focus is on premium and super premium brands. The Group has two reportable geographic segments: Australia and the United States.